Guru Ownership Trend
Guru Analysis for Avadel Pharmaceuticals plc (AVDL)
Avadel Pharmaceuticals plc (AVDL), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $12.4 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.3 M net outflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Cliff Asness reduced exposure by 70.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Avadel Pharmaceuticals plc (AVDL)
Major holders include Steven Cohen ($6.02 M), Renaissance Technologies (RenTech) ($5.9 M), Cliff Asness ($430,204). According to the latest reported data, 3 tracked investment managers collectively hold approximately 573,088 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.3 M, with 1 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited AVDL. The total reported sell value was $7.32 M.
Yes, 1 managers opened new positions in AVDL, and 0 increased their existing holdings. The total reported buy value was $6.02 M.